tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders StocksMarket MoversTipRanks 50 IndexDividend StocksAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Research Tools
Trending StocksCompare StocksCompare ETFsTrump Dashboard
New
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Trending News
More News >
Education
Personal FinanceHow To Use TipRanksTipRanks LabsWebinar CenterGlossaryFAQs
About Us
About TipRanksContact UsCareersReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News Wire
Follow Us
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders Stocks
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Trump Dashboard
New
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Advertisement
Advertisement

JANX Stock Latest News

Janux Therapeutics: Strategic Innovations and Robust Pipeline Drive Buy Rating
RatingsJanux Therapeutics: Strategic Innovations and Robust Pipeline Drive Buy Rating
8d ago
JANX
Optimistic Buy Rating for Janux Therapeutics Driven by Strategic Pipeline and Diversification
PremiumRatings
Optimistic Buy Rating for Janux Therapeutics Driven by Strategic Pipeline and Diversification
8d ago
JANX
Janux Therapeutics Inc: Strategic Advancements and Strong Positioning in Oncology Drive Buy Rating
PremiumRatings
Janux Therapeutics Inc: Strategic Advancements and Strong Positioning in Oncology Drive Buy Rating
11d ago
JANX
Janux Therapeutics’ Strategic Expansion and Promising Pipeline Drive Buy Rating
PremiumRatings
Janux Therapeutics’ Strategic Expansion and Promising Pipeline Drive Buy Rating
11d ago
JANX
Janux Therapeutics Faces Trade Policy Challenges: Impact on Operations and Growth
PremiumCompany Announcements
Janux Therapeutics Faces Trade Policy Challenges: Impact on Operations and Growth
11d ago
JANX
Innovative Preclinical Programs and Strategic Tumor Activation Drive Buy Rating for Janux Therapeutics
PremiumRatingsInnovative Preclinical Programs and Strategic Tumor Activation Drive Buy Rating for Janux Therapeutics
12d ago
JANX
Strategic Initiatives and Long-Term Potential Drive Buy Rating for Janux Therapeutics Inc.
Premium
Ratings
Strategic Initiatives and Long-Term Potential Drive Buy Rating for Janux Therapeutics Inc.
15d ago
JANX
CoreWeave initiated, Texas Instruments upgraded: Wall Street’s top analyst calls
Premium
The Fly
CoreWeave initiated, Texas Instruments upgraded: Wall Street’s top analyst calls
25d ago
AMC
BYD
Janux Therapeutics initiated with an Outperform at Raymond James
PremiumThe Fly
Janux Therapeutics initiated with an Outperform at Raymond James
25d ago
JANX
Janux Therapeutics Holds 2025 Annual Stockholders Meeting
PremiumCompany Announcements
Janux Therapeutics Holds 2025 Annual Stockholders Meeting
2M ago
8K
JANX
Promising Developments and Market Potential of Janux Therapeutics Inc.: A Focus on JANX007 and JANX008 Trials
PremiumRatings
Promising Developments and Market Potential of Janux Therapeutics Inc.: A Focus on JANX007 and JANX008 Trials
3M ago
JANX
Janux appoints Janeen Doyle chief corporate, business development officer
PremiumThe Fly
Janux appoints Janeen Doyle chief corporate, business development officer
3M ago
JANX
Janux Therapeutics Reports Increased Q1 Losses Amid R&D Expansion
PremiumCompany AnnouncementsJanux Therapeutics Reports Increased Q1 Losses Amid R&D Expansion
3M ago
JANX
JANX Earnings Report this Week: Is It a Buy, Ahead of Earnings?
Premium
Pre-Earnings
JANX Earnings Report this Week: Is It a Buy, Ahead of Earnings?
3M ago
JANX
Janux Therapeutics price target lowered to $36 from $41 at Scotiabank
Premium
The Fly
Janux Therapeutics price target lowered to $36 from $41 at Scotiabank
3M ago
JANX
Promising Pipeline and Strategic Advancements Justify Buy Rating for Janux Therapeutics Inc
PremiumRatings
Promising Pipeline and Strategic Advancements Justify Buy Rating for Janux Therapeutics Inc
3M ago
JANX
Positive Buy Rating for Janux Therapeutics Inc. Driven by Promising Clinical Data and Strong Financial Position
PremiumRatings
Positive Buy Rating for Janux Therapeutics Inc. Driven by Promising Clinical Data and Strong Financial Position
3M ago
JANX
Buy Rating Affirmed for Janux Therapeutics: Promising Clinical Data and Superior Efficacy of Lead Program JANX007
PremiumRatings
Buy Rating Affirmed for Janux Therapeutics: Promising Clinical Data and Superior Efficacy of Lead Program JANX007
3M ago
JANX
Janux Therapeutics Inc: Undervalued Growth Potential Amid Recent Stock Pullback
PremiumRatings
Janux Therapeutics Inc: Undervalued Growth Potential Amid Recent Stock Pullback
3M ago
JANX
Janux Therapeutics reports Q1 EPS (38c), consensus (39c)
PremiumThe FlyJanux Therapeutics reports Q1 EPS (38c), consensus (39c)
3M ago
JANX
Buy Rating for Janux Therapeutics Inc. Driven by Strategic Advancements in Prostate Cancer Treatment with JANX007
Premium
Ratings
Buy Rating for Janux Therapeutics Inc. Driven by Strategic Advancements in Prostate Cancer Treatment with JANX007
3M ago
JANX
Buy Rating for Janux Therapeutics Inc: Promising PFS Data and Attractive Valuation
Premium
Ratings
Buy Rating for Janux Therapeutics Inc: Promising PFS Data and Attractive Valuation
3M ago
JANX

Trending

Name
Price
Price Change
SPX
S&P 500
DJIA
Dow Jones
NDX
Nasdaq 100
More Trending Stocks >